{
  "authors": [
    {
      "author": "Kishan Soni"
    },
    {
      "author": "Tarun Kumar"
    },
    {
      "author": "Manoj Pandey"
    }
  ],
  "doi": "10.1186/s12957-020-01934-4",
  "publication_date": "2020-07-06",
  "id": "EN110840",
  "url": "https://pubmed.ncbi.nlm.nih.gov/32622356",
  "source": "World journal of surgical oncology",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "A 60-year-old woman presented with pain in abdomen and loss of appetite for 1 month, and imaging showed locally advanced gallbladder carcinoma with liver metastasis. After biopsy confirmation, patient was initially started on gemcitabine and oxaliplatin combination followed by gene sequencing, which showed Tp53 (exon 7-c.713 G > A and exon 5-c.376-2A > G) and EGFR (exon 20-T790M) mutation, and erlotinib was added to chemotherapy, after 6 cycles of chemotherapy patient showed a 90% partial radiological response as per RECIST criteria."
}